Drugs / Novolog® Mix 70/30
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00384085 | May 2006 → Mar 2010 | type 2 diabetes mellitus | Sanofi | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Novolog Mix 70/30 | “Premixed insulin (Novolog® Mix 70/30) added to oral agents.” NCT00384085 ↗ |
| Route | Subcutaneous | “Subcutaneous injection twice-a-day.” NCT00384085 ↗ |